Surgery
Volume 145, Issue 6 , Pages 663-674 , June 2009

Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection

  • Fan He, MD

      Affiliations

    • Division of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
    • Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
  • ,
  • Zhishui Chen, MD, PhD

      Affiliations

    • Institution of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
    • Corresponding Author InformationReprint requests: Zhishui Chen, MD, PhD, Institution of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China.
  • ,
  • Shengyuan Xu, MA

      Affiliations

    • Institution of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
  • ,
  • Ming Cai, PhD

      Affiliations

    • Institution of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
  • ,
  • Min Wu, PhD

      Affiliations

    • Institution of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
  • ,
  • Hongzhou Li, MA

      Affiliations

    • Institution of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
  • ,
  • Xiaoping Chen, MD, PhD

      Affiliations

    • Institution of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

,Accepted 15 January 2009.

References 

  1. Crispe IN, Giannandrea M, Klein I, et al. Cellular and molecular mechanisms of liver tolerance. Immunol Rev. 2006;213:101–118
  2. Crispe IN. Hepatic T cells and liver tolerance. Nat Rev Immunol. 2003;3:51–62
  3. Margenthaler JA, Landeros K, Kataoka M, et al. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice. Transpl Immunol. 2003;11:23–29
  4. Wong W, Morris PJ, Wood KJ. Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: evidence for linked epitope suppression. Transplantation. 1997;63:1490–1494
  5. Lau J, Mattsson G, Carlsson C, et al. Implantation site-dependent dysfunction of transplanted pancreatic islets. Diabetes. 2007;56:1544–1550
  6. Limmer A, Ohl J, Kurts C, et al. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat Med. 2000;6:1348–1354
  7. Knolle PA, Schmitt E, Jin S, et al. Induction of cytokine production in naïve CD4 (+) T cells by antigen-presenting murine LSECs but failure to induce differentiation toward Th1 cells. Gastroenterology. 1999;116:1428–1440
  8. Watanabe T, Katsukura H, Shirai Y, et al. A liver tolerates a portal antigen by generating CD11c cells, which select Fas Ligand Th2 cells via apoptosis. Hepatology. 2003;38:403–412
  9. Lu L, Bonham CA, Liang X, et al. Liver-derived DEC205+B220+CD19- dendritic cells regulate T cell responses. J Immunol. 2001;166:7042–7052
  10. You Q, Cheng L, Kedl RM, et al. Mechanism of T cell tolerance induction by murine hepatic Kupffer cells. Hepatology. 2008;48:978–990
  11. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell. 2000;101:455–458
  12. Morse MA, Clay TM, Mosca P, et al. Immunoregulatory T cells in cancer immunotherapy. Expert Opin Biol Ther. 2002;2:827–834
  13. Shevach EM, McHugh RS, Piccirillo CA, et al. Control of T-cell activation by CD4+CD25+ suppressor T cells. Immunol Rev. 2001;182:58–67
  14. Piccirillo CA, Shevach EM. Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J Immunol. 2001;167:1137–1140
  15. Woo EY, Yeh H, Chu CS, et al. Cutting edge: regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol. 2002;168:4272–4276
  16. Li W, Zheng XX, Kuhr CS, Perkins JD. CTLA4 engagement is required for induction of murine liver transplant spontaneous tolerance. Am J Transplant. 2005;5:978–986
  17. Lan RY, Cheng C, Lian ZX, et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology. 2006;43:729–737
  18. Longhi MS, Ma Y, Bogdanos DP, et al. Impairment of CD4(+) CD25 (+) regulatory T-cells in autoimmune liver disease. J Hepatol. 2004;41:31–37
  19. Demirkiran A, Bosma BM, Kok A, et al. Allosuppressive donor CD4+CD25+ regulatory T cells detach from the graft and circulate in recipients after liver transplantation. J Immunol. 2007;178:6066–6072
  20. Chen Z. A technique of cervical heterotopic heart transplantation in mice. Transplantation. 1991;52:1099–1101
  21. Tokita D, Shishida M, Ohdan H, et al. LSECs that endocytose allogeneic cells suppress T cells with indirect allospecificity. J Immunol. 2006;177:3615–3624
  22. Morita H, Sugiura K, Inaba M, et al. A strategy for organ allografts without using immunosuppression or irradiation. Proc Natl Acad Sci U S A. 1998;95:6947–6952
  23. Yagi H, Nomura T, Nakamura K, et al. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol. 2004;16:1643–1656
  24. Hong J, Li N, Zhang X, et al. Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3. Proc Natl Acad Sci U S A. 2005;102:6449–6454
  25. Kohm AP, McMahon JS, Podojil JR, et al. Cutting Edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells. J Immunol. 2006;176:3301–3305
  26. Jiang X, Morita M, Sugioka A, et al. The importance of CD25+ CD4+ regulatory T cells in mouse hepatic allograft tolerance. Liver Transpl. 2006;12:1112–1118
  27. Li W, Kuhr CS, Zheng XX, et al. New insights into mechanisms of spontaneous liver transplant tolerance: the role of Foxp3-expressing CD25+CD4+ regulatory T cells. Am J Transplant. 2008;8:1639–1651
  28. Li W, Carper K, Liang Y. Anti-CD25 mAb administration prevents spontaneous liver transplant tolerance. Transplant Proc. 2006;38:3207–3208
  29. lad G, Ho EK, Vasilescu ER, et al. Anti-CD25 treatment and FOXP3-positive regulatory T cells in heart transplantation. Transpl Immunol. 2007;18:13–21
  30. Pan H, Lu HM, Hu WM, et al. Anti-CD25 mAb, anti-IL2 mAb, and IL2 block tolerance induction through anti-CD154 mAb and rapamycin in xenogeneic islet transplantation. Transplant Proc. 2007;39:3452–3454
  31. Morelli AE, O'Connell PJ, Khanna A, et al. Preferential induction of Th1 responses by functionally mature hepatic (CD8alpha- and CD8alpha+) dendritic cells: association with conversion from liver transplant tolerance to acute rejection. Transplantation. 2000;69:2647–2657
  32. Winstead CJ, Fraser JM, Khoruts A. Regulatory CD4+CD25+Foxp3+ T cells selectively inhibit the spontaneous form of lymphopenia-induced proliferation of naive T cells. J Immunol. 2008;180:7305–7317
  33. Wiegard C, Frenzel C, Herkel J, et al. Murine liver antigen presenting cells control suppressor activity of CD4+CD25+ regulatory T cells. Hepatology. 2005;42:193–199
  34. Trzonkowski P, Szmit E, Mysliwska J, et al. CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction. Clin Immunol. 2004;112:258–267
  35. McKee AS, Pearce EJ. CD25+CD4+ cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development. J Immunol. 2004;173:1224–1231
  36. Pace L, Pioli C, Doria G. IL-4 modulation of CD4+CD25+ T regulatory cell-mediated suppression. J Immunol. 2005;174:7645–7653
  37. Pace L, Rizzo S, Palombi C, et al. Cutting edge: IL-4-induced protection of CD4+CD25-Th cells from CD4+CD25+ regulatory T cell-mediated suppression. J Immunol. 2006;176:3900–3904
  38. Ke B, Ritter T, Kato H, et al. Regulatory cells potentiate the efficacy of IL-4 gene transfer by up-regulating Th2-dependent expression of protective molecules in the infectious tolerance pathway in transplant recipients. J Immunol. 2000;164:5739–5745
  39. MacDonald KP, Rowe V, Clouston AD, et al. Cytokine expanded myeloid precursors function as regulatory antigen-presenting cells and promote tolerance through IL-10-producing regulatory T cells. J Immunol. 2005;174:1841–1850
  40. Pandiyan P, Zheng L, Ishihara S, et al. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat Immunol. 2007;8:1353–1362
  41. Dai Z, Li Q, Wang Y, et al. CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism. J Clin Invest. 2004;113:310–317

 Supported by the Key Program of Science and Technology of Hubei Province, China, No. 2006AA301A06.

PII: S0039-6060(09)00086-5

doi: 10.1016/j.surg.2009.01.016

Surgery
Volume 145, Issue 6 , Pages 663-674 , June 2009